← Back to Search

Multimodal Treatments for Chronic Lower Back Pain (BACPAC Trial)

Phase 4
Recruiting
Led By Afton Hassett, PsyD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Acupressure: Currently receiving acupressure or acupuncture through formal therapy
Normal visual acuity or correctable (with corrective lenses- glasses or contacts) to at least 20/40 for reading instructions in the MRI and visual sensitivity testing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 6 (t2), week 15 (t3)
Awards & highlights

BACPAC Trial Summary

This trial will help identify who benefits from different chronic pain treatments and how these treatments work.

Who is the study for?
This trial is for individuals with chronic lower back pain lasting at least six months, who are right-handed, can lie still for MRI scans, and don't have severe health issues like osteoporosis or uncontrolled addiction. Participants must not be pregnant, involved in other conflicting studies, expecting surgery within a year, or on high opioid doses.Check my eligibility
What is being tested?
The study tests four treatments: mindfulness-based stress reduction (MBSR), physical therapy with exercise, self-administered acupressure, and the medication duloxetine. After an initial assessment period using PainGuide and MRIs among others tools participants may receive two different treatments sequentially if they still have significant pain.See study design
What are the potential side effects?
Possible side effects include typical reactions to mindfulness practices such as discomfort during meditation; physical therapy might cause muscle soreness; acupressure could result in bruising or tenderness; duloxetine may lead to nausea, dry mouth, sleepiness or dizziness.

BACPAC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently undergoing acupressure or acupuncture therapy.
Select...
My vision, with glasses or contacts, is good enough to read MRI instructions.
Select...
I can stay still on my back for 2 hours.

BACPAC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 6 (t2), week 15 (t3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 6 (t2), week 15 (t3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) pain interference 4a between week 6 to week 15
Secondary outcome measures
Change in Patient Global Impression of Change (PGIC) from week 6 to week 15
Dental Pins

BACPAC Trial Design

17Treatment groups
Experimental Treatment
Group I: PainGuideExperimental Treatment1 Intervention
Run-in treatment only with no additional treatments.
Group II: PT and exercise then MBSRExperimental Treatment4 Interventions
Run-in treatment, then 8 weeks of PT and exercise, and then 8 weeks of MBSR.
Group III: PT and exercise then DuloxetineExperimental Treatment4 Interventions
Run-in treatment, then 8 weeks of PT and exercise, and then approximately 8 weeks of Duloxetine
Group IV: PT and exercise then AcupressureExperimental Treatment4 Interventions
Run-in treatment, then 8 weeks of PT and exercise, and then 8 weeks of Acupressure
Group V: PT and exerciseExperimental Treatment3 Interventions
Run-in treatment then PT and exercise
Group VI: MBSR then PT and exerciseExperimental Treatment4 Interventions
Run-in treatment then 8 weeks of MBSR, and then 8 weeks of PT and exercise.
Group VII: MBSR then DuloxetineExperimental Treatment4 Interventions
Run-in treatment, then 8 weeks of MBSR, and then approximately 8 weeks of Duloxetine
Group VIII: MBSR then AcupressureExperimental Treatment4 Interventions
Run-in treatment, then 8 weeks of MBSR, and then 8 weeks Acupressure.
Group IX: MBSR (mindfulness-based stress reduction)Experimental Treatment3 Interventions
Run-in treatment then MBSR.
Group X: Duloxetine then PT and exerciseExperimental Treatment4 Interventions
Run-in treatment, then approximately 8 weeks of Duloxetine, and then 8 weeks of PT and exercise
Group XI: Duloxetine then MBSRExperimental Treatment4 Interventions
Run-in treatment, then approximately 8 weeks of Duloxetine, and then 8 weeks of MBSR.
Group XII: Duloxetine then AcupressureExperimental Treatment4 Interventions
Run-in treatment, then approximately 8 weeks of Duloxetine, and then 8 weeks Acupressure.
Group XIII: DuloxetineExperimental Treatment3 Interventions
Run-in treatment then Duloxetine
Group XIV: Acupressure then PT and exerciseExperimental Treatment4 Interventions
Run-in treatment, then 8 weeks of Acupressure, and then 8 weeks of PT and exercise.
Group XV: Acupressure then MBSRExperimental Treatment4 Interventions
Run-in treatment, then 8 weeks of Acupressure, and then 8 weeks of MBSR
Group XVI: Acupressure then DuloxetineExperimental Treatment4 Interventions
Run-in treatment, then 8 weeks of Acupressure, and then approximately 8 weeks of Duloxetine
Group XVII: AcupressureExperimental Treatment3 Interventions
Run-in treatment then Acupressure
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MBSR
2016
Completed Phase 3
~1940
Duloxetine
2011
Completed Phase 4
~4170

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,798 Previous Clinical Trials
6,377,638 Total Patients Enrolled
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH
484 Previous Clinical Trials
1,086,345 Total Patients Enrolled
Afton Hassett, PsyDPrincipal Investigator - University of Michigan
University of Michigan
1 Previous Clinical Trials
2 Total Patients Enrolled

Media Library

Duloxetine Clinical Trial Eligibility Overview. Trial Name: NCT04870957 — Phase 4
Chronic Lower Back Pain Research Study Groups: MBSR then Duloxetine, PainGuide, PT and exercise then Acupressure, MBSR then Acupressure, PT and exercise then MBSR, Duloxetine then PT and exercise, Duloxetine then Acupressure, MBSR (mindfulness-based stress reduction), PT and exercise, Acupressure, Duloxetine, MBSR then PT and exercise, PT and exercise then Duloxetine, Acupressure then MBSR, Acupressure then PT and exercise, Acupressure then Duloxetine, Duloxetine then MBSR
Chronic Lower Back Pain Clinical Trial 2023: Duloxetine Highlights & Side Effects. Trial Name: NCT04870957 — Phase 4
Duloxetine 2023 Treatment Timeline for Medical Study. Trial Name: NCT04870957 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the criteria for this clinical experiment extend to participants in their mid-forties or beyond?

"This study is open to individuals aged 25-70. There are 12 trials available for minors and 277 studies that focus on patients over 65 years old."

Answered by AI

Is this research team currently looking for participants?

"Affirmative. Clinicaltrials.gov confirms that this trial is currently recruiting patients, with the first post being on June 9th 2021 and last edited on June 13th 2022. 500 individuals need to be admitted from one site in order for the study to continue progressing."

Answered by AI

What remedial treatment do physical therapy and exercise typically provide?

"Physiotherapy and exercise can provide therapeutic benefits for those with diabetic peripheral neuropathy (DPN). Additionally, it can be employed to address knee problems, major depressive disorder (MDD), as well as issues pertaining to the musculoskeletal system."

Answered by AI

Are there certain qualifications that must be met to partake in this medical experiment?

"Eligibility for this trial necessitates sufferers of chronic lower back pain (CLBP) between the ages 25 and 70. Five hundred participants are needed in order to meet recruitment goals."

Answered by AI

Could you please elucidate on any other research projects that have studied the relationship between physical therapy and exercise?

"Currently, there are 22 medical experiments assessing the efficacy of physical therapy and exercise. Of these studies, 4 have reached Phase 3. Although Redwood City, California houses many of the investigations for PT and exercise, globally 781 sites operate trials related to this field."

Answered by AI

How many individuals are being accepted into this clinical trial program?

"Affirmative. Clinicaltrials.gov evidences that this clinical experiment, which was initially posted on June 9th 2021, is actively seeking participants. The study requires the recruitment of 500 individuals from a single medical centre."

Answered by AI

Are physical therapy and exercise activities associated with any severe risks?

"Power's assessment of the safety profile for physical therapy and exercise is a 3, as it has been approved in Phase 4 clinical trials."

Answered by AI

Who else is applying?

What site did they apply to?
University of Michigan
What portion of applicants met pre-screening criteria?
Met criteria

What questions have other patients asked about this trial?

1. How much should I expect this trial to pay? 2. What length of time should I expect this trial to take in order to complete and receive compensation? 3. Will this trial require time outside of in-office visits at the Ann-Arbor trial location? If so, how much time and in what ways? 4. How long should I expect the screening process to take?
PatientReceived 1 prior treatment
~261 spots leftby Jun 2027